Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020004027> ?p ?o ?g. }
- W2020004027 endingPage "2653" @default.
- W2020004027 startingPage "2643" @default.
- W2020004027 abstract "Background Prognosis of patients with pancreatic adenocarcinoma (PAC) remains poor. S100A2 has been recently suggested as a negative prognostic biomarker in PAC. We aimed to investigate its prognostic and/or predictive value in a large independent multicentric cohort of patients with resected PAC. Methods Sequential samples of 471 patients were retrospectively collected; 142 patients did not receive adjuvant treatment (30%) and 329 (70%) received an adjuvant treatment. We measured protein levels of S100A2 by semiquantitative immunohistochemistry with tissue microarrays and correlated with patients’ overall survival (OS) and disease-free survival (DFS). Results S100A2 protein status was obtained in 462 (98%) patients. Its expression was low, moderate or high in 59%, 12% and 2% of cases, respectively. It was not correlated with DFS or OS in the whole population, neither in the subgroup of patients who did not receive adjuvant treatment. However among patients who received an adjuvant therapy, moderate/high levels of S100A2 were significantly associated with longer OS and DFS in multivariate analysis (hazard ratios of 0.63, p= 0.022 and 0.67, p= 0.017, respectively), whereas low S100A2 was not. Interaction tests for adjuvant therapy were statistically significant both for the OS and the DFS (p= 0.001 and p= 0.023, respectively). On multivariate analysis, S100A2 retained independent predictive values (OS: p< 0.001, DFS: p= 0.003) with a significant benefit of adjuvant therapy for those patients with moderate/high S100A2. Conclusions S100A2 expression predicts longer DFS and OS in patients treated with adjuvant therapy and should be evaluated as a predictive biomarker." @default.
- W2020004027 created "2016-06-24" @default.
- W2020004027 creator A5002063921 @default.
- W2020004027 creator A5004786546 @default.
- W2020004027 creator A5005989819 @default.
- W2020004027 creator A5006839571 @default.
- W2020004027 creator A5007810585 @default.
- W2020004027 creator A5010902289 @default.
- W2020004027 creator A5015341752 @default.
- W2020004027 creator A5027803580 @default.
- W2020004027 creator A5035154674 @default.
- W2020004027 creator A5042816102 @default.
- W2020004027 creator A5046772863 @default.
- W2020004027 creator A5049515095 @default.
- W2020004027 creator A5060346666 @default.
- W2020004027 creator A5062356516 @default.
- W2020004027 creator A5064556770 @default.
- W2020004027 creator A5070179654 @default.
- W2020004027 creator A5085079548 @default.
- W2020004027 date "2013-08-01" @default.
- W2020004027 modified "2023-10-18" @default.
- W2020004027 title "S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma" @default.
- W2020004027 cites W1973631031 @default.
- W2020004027 cites W1982245010 @default.
- W2020004027 cites W2010399001 @default.
- W2020004027 cites W2012176955 @default.
- W2020004027 cites W2020016182 @default.
- W2020004027 cites W2032491192 @default.
- W2020004027 cites W2036222374 @default.
- W2020004027 cites W2047318784 @default.
- W2020004027 cites W2064200041 @default.
- W2020004027 cites W2065140692 @default.
- W2020004027 cites W2076151940 @default.
- W2020004027 cites W2085674426 @default.
- W2020004027 cites W2086050575 @default.
- W2020004027 cites W2090071430 @default.
- W2020004027 cites W2090950165 @default.
- W2020004027 cites W2096849147 @default.
- W2020004027 cites W2098348379 @default.
- W2020004027 cites W2101995865 @default.
- W2020004027 cites W2108710215 @default.
- W2020004027 cites W2117262727 @default.
- W2020004027 cites W2122686902 @default.
- W2020004027 cites W2125841356 @default.
- W2020004027 cites W2129197203 @default.
- W2020004027 cites W2133463872 @default.
- W2020004027 cites W2138482180 @default.
- W2020004027 cites W2145767879 @default.
- W2020004027 cites W2150699859 @default.
- W2020004027 cites W2151253787 @default.
- W2020004027 cites W2154790710 @default.
- W2020004027 cites W2157590016 @default.
- W2020004027 cites W2159441446 @default.
- W2020004027 cites W2166022333 @default.
- W2020004027 cites W2170202192 @default.
- W2020004027 cites W2218904682 @default.
- W2020004027 cites W2462266144 @default.
- W2020004027 cites W2590182035 @default.
- W2020004027 doi "https://doi.org/10.1016/j.ejca.2013.04.017" @default.
- W2020004027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23726265" @default.
- W2020004027 hasPublicationYear "2013" @default.
- W2020004027 type Work @default.
- W2020004027 sameAs 2020004027 @default.
- W2020004027 citedByCount "32" @default.
- W2020004027 countsByYear W20200040272014 @default.
- W2020004027 countsByYear W20200040272015 @default.
- W2020004027 countsByYear W20200040272016 @default.
- W2020004027 countsByYear W20200040272018 @default.
- W2020004027 countsByYear W20200040272019 @default.
- W2020004027 countsByYear W20200040272020 @default.
- W2020004027 countsByYear W20200040272021 @default.
- W2020004027 countsByYear W20200040272022 @default.
- W2020004027 countsByYear W20200040272023 @default.
- W2020004027 crossrefType "journal-article" @default.
- W2020004027 hasAuthorship W2020004027A5002063921 @default.
- W2020004027 hasAuthorship W2020004027A5004786546 @default.
- W2020004027 hasAuthorship W2020004027A5005989819 @default.
- W2020004027 hasAuthorship W2020004027A5006839571 @default.
- W2020004027 hasAuthorship W2020004027A5007810585 @default.
- W2020004027 hasAuthorship W2020004027A5010902289 @default.
- W2020004027 hasAuthorship W2020004027A5015341752 @default.
- W2020004027 hasAuthorship W2020004027A5027803580 @default.
- W2020004027 hasAuthorship W2020004027A5035154674 @default.
- W2020004027 hasAuthorship W2020004027A5042816102 @default.
- W2020004027 hasAuthorship W2020004027A5046772863 @default.
- W2020004027 hasAuthorship W2020004027A5049515095 @default.
- W2020004027 hasAuthorship W2020004027A5060346666 @default.
- W2020004027 hasAuthorship W2020004027A5062356516 @default.
- W2020004027 hasAuthorship W2020004027A5064556770 @default.
- W2020004027 hasAuthorship W2020004027A5070179654 @default.
- W2020004027 hasAuthorship W2020004027A5085079548 @default.
- W2020004027 hasConcept C126322002 @default.
- W2020004027 hasConcept C143998085 @default.
- W2020004027 hasConcept C185592680 @default.
- W2020004027 hasConcept C207103383 @default.
- W2020004027 hasConcept C2776694085 @default.
- W2020004027 hasConcept C2777863537 @default.
- W2020004027 hasConcept C2777982462 @default.